Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georges Gebrael

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Med (New York, N.Y.)|November 15, 2025
Metastatic prostate cancer: Clinical trials to watchGeorges Gebrael, Micah Ostrowski, Neeraj Agarwal
The Oncologist|August 19, 2023
Racial Disparities and Molecular Insights in Translocation Renal Cell Carcinoma: Advancing Understanding and Treatment ApproachesPatrick Campbell, Georges Gebrael, Neeraj Agarwal
JCO Precision Oncology|November 16, 2023
Differential Impact of <i>SPOP</i> Mutation in Prostate and Endometrial CancersGeorges Gebrael, Zeynep Zengin, Umang Swami
Med (New York, N.Y.)|November 9, 2024
[<sup>89</sup>Zr]Zr-girentuximab PET-CT imaging to diagnose, characterize, and differentiate clear-cell renal cell carcinomaChadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
JAMA Oncology|June 22, 2023
Developing an Ideal Risk Stratification Model for Metastatic Renal Cell CarcinomaGeorges Gebrael, Gliceida Galarza Fortuna, Neeraj Agarwal
Cancer Discovery|January 12, 2024
Bispecific T-cell Engagers in Metastatic Castration-Resistant Prostate CancerChadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
Translational Andrology and Urology|June 18, 2025
Metastatic renal cell carcinoma disease response in the era of immune checkpoint inhibitor-based combinationsMicah Ostrowski, Georges Gebrael, Benjamin L Maughan
The Lancet. Oncology|July 10, 2025
Metformin in prostate cancerGeorges Gebrael, Chadi Hage Chehade, Neeraj Agarwal
The Oncologist|April 4, 2023
The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World PracticeGeorges Gebrael, Vinay Mathew Thomas, Umang Swami, et al.
Human Vaccines & Immunotherapeutics|April 17, 2023
Update on combined immunotherapy for the treatment of advanced renal cell carcinomaGeorges Gebrael, Kamal Kant Sahu, Neeraj Agarwal, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Med (New York, N.Y.)|November 15, 2025
Metastatic prostate cancer: Clinical trials to watchGeorges Gebrael, Micah Ostrowski, Neeraj Agarwal
The Oncologist|August 19, 2023
Racial Disparities and Molecular Insights in Translocation Renal Cell Carcinoma: Advancing Understanding and Treatment ApproachesPatrick Campbell, Georges Gebrael, Neeraj Agarwal
JCO Precision Oncology|November 16, 2023
Differential Impact of <i>SPOP</i> Mutation in Prostate and Endometrial CancersGeorges Gebrael, Zeynep Zengin, Umang Swami
Med (New York, N.Y.)|November 9, 2024
[<sup>89</sup>Zr]Zr-girentuximab PET-CT imaging to diagnose, characterize, and differentiate clear-cell renal cell carcinomaChadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
JAMA Oncology|June 22, 2023
Developing an Ideal Risk Stratification Model for Metastatic Renal Cell CarcinomaGeorges Gebrael, Gliceida Galarza Fortuna, Neeraj Agarwal
Cancer Discovery|January 12, 2024
Bispecific T-cell Engagers in Metastatic Castration-Resistant Prostate CancerChadi Hage Chehade, Georges Gebrael, Neeraj Agarwal
Translational Andrology and Urology|June 18, 2025
Metastatic renal cell carcinoma disease response in the era of immune checkpoint inhibitor-based combinationsMicah Ostrowski, Georges Gebrael, Benjamin L Maughan
The Lancet. Oncology|July 10, 2025
Metformin in prostate cancerGeorges Gebrael, Chadi Hage Chehade, Neeraj Agarwal
The Oncologist|April 4, 2023
The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World PracticeGeorges Gebrael, Vinay Mathew Thomas, Umang Swami, et al.
Human Vaccines & Immunotherapeutics|April 17, 2023
Update on combined immunotherapy for the treatment of advanced renal cell carcinomaGeorges Gebrael, Kamal Kant Sahu, Neeraj Agarwal, et al.
Pageof 6